A two-stage approach to genetic risk assessment in primary care

Swati Biswas, Philamer Atienza, Jonathan Chipman, Amanda L. Blackford, Banu Arun, Kevin Hughes, Giovanni Parmigiani

Research output: Contribution to journalArticle

Abstract

Genetic risk prediction models such as BRCAPRO are used routinely in genetic counseling for identification of potential BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus are not practical for primary care. To address this gap, we develop and test a two-stage approach to genetic risk assessment by balancing the tradeoff between the amount of information used and accuracy achieved. The first stage is intended for primary care wherein limited information is collected and analyzed using a simplified version of BRCAPRO. If the assessed risk is sufficiently high, more extensive information is collected and the full BRCAPRO is used (stage two: intended for genetic counseling). We consider three first-stage tools: BRCAPROLYTE, BRCAPROLYTE-Plus, and BRCAPROLYTE-Simple. We evaluate the two-stage approach on independent clinical data on probands with family history of breast and ovarian cancers, and BRCA genetic test results. These include population-based data on 1344 probands from Newton-Wellesley Hospital and mostly high-risk family data on 2713 probands from Cancer Genetics Network and MD Anderson Cancer Center. We use discrimination and calibration measures, appropriately modified to evaluate the overall performance of a two-stage approach. We find that the proposed two-stage approach has very limited loss of discrimination and comparable calibration as BRCAPRO. It identifies a similar number of carriers without requiring a full family history evaluation on all probands. We conclude that the two-stage approach allows for practical large-scale genetic risk assessment in primary care.

Original languageEnglish (US)
Pages (from-to)375-383
Number of pages9
JournalBreast Cancer Research and Treatment
Volume155
Issue number2
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Primary Health Care
Genetic Counseling
Calibration
Ovarian Neoplasms
Neoplasms
Breast Neoplasms
Mutation
Population

Keywords

  • BayesMendel
  • BRCA1
  • BRCA2
  • BRCAPRO
  • CancerGene

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Biswas, S., Atienza, P., Chipman, J., Blackford, A. L., Arun, B., Hughes, K., & Parmigiani, G. (2016). A two-stage approach to genetic risk assessment in primary care. Breast Cancer Research and Treatment, 155(2), 375-383. https://doi.org/10.1007/s10549-016-3686-2

A two-stage approach to genetic risk assessment in primary care. / Biswas, Swati; Atienza, Philamer; Chipman, Jonathan; Blackford, Amanda L.; Arun, Banu; Hughes, Kevin; Parmigiani, Giovanni.

In: Breast Cancer Research and Treatment, Vol. 155, No. 2, 01.01.2016, p. 375-383.

Research output: Contribution to journalArticle

Biswas, S, Atienza, P, Chipman, J, Blackford, AL, Arun, B, Hughes, K & Parmigiani, G 2016, 'A two-stage approach to genetic risk assessment in primary care', Breast Cancer Research and Treatment, vol. 155, no. 2, pp. 375-383. https://doi.org/10.1007/s10549-016-3686-2
Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K et al. A two-stage approach to genetic risk assessment in primary care. Breast Cancer Research and Treatment. 2016 Jan 1;155(2):375-383. https://doi.org/10.1007/s10549-016-3686-2
Biswas, Swati ; Atienza, Philamer ; Chipman, Jonathan ; Blackford, Amanda L. ; Arun, Banu ; Hughes, Kevin ; Parmigiani, Giovanni. / A two-stage approach to genetic risk assessment in primary care. In: Breast Cancer Research and Treatment. 2016 ; Vol. 155, No. 2. pp. 375-383.
@article{31ba390aff7142e4807ba68d16899ecc,
title = "A two-stage approach to genetic risk assessment in primary care",
abstract = "Genetic risk prediction models such as BRCAPRO are used routinely in genetic counseling for identification of potential BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus are not practical for primary care. To address this gap, we develop and test a two-stage approach to genetic risk assessment by balancing the tradeoff between the amount of information used and accuracy achieved. The first stage is intended for primary care wherein limited information is collected and analyzed using a simplified version of BRCAPRO. If the assessed risk is sufficiently high, more extensive information is collected and the full BRCAPRO is used (stage two: intended for genetic counseling). We consider three first-stage tools: BRCAPROLYTE, BRCAPROLYTE-Plus, and BRCAPROLYTE-Simple. We evaluate the two-stage approach on independent clinical data on probands with family history of breast and ovarian cancers, and BRCA genetic test results. These include population-based data on 1344 probands from Newton-Wellesley Hospital and mostly high-risk family data on 2713 probands from Cancer Genetics Network and MD Anderson Cancer Center. We use discrimination and calibration measures, appropriately modified to evaluate the overall performance of a two-stage approach. We find that the proposed two-stage approach has very limited loss of discrimination and comparable calibration as BRCAPRO. It identifies a similar number of carriers without requiring a full family history evaluation on all probands. We conclude that the two-stage approach allows for practical large-scale genetic risk assessment in primary care.",
keywords = "BayesMendel, BRCA1, BRCA2, BRCAPRO, CancerGene",
author = "Swati Biswas and Philamer Atienza and Jonathan Chipman and Blackford, {Amanda L.} and Banu Arun and Kevin Hughes and Giovanni Parmigiani",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s10549-016-3686-2",
language = "English (US)",
volume = "155",
pages = "375--383",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - A two-stage approach to genetic risk assessment in primary care

AU - Biswas, Swati

AU - Atienza, Philamer

AU - Chipman, Jonathan

AU - Blackford, Amanda L.

AU - Arun, Banu

AU - Hughes, Kevin

AU - Parmigiani, Giovanni

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Genetic risk prediction models such as BRCAPRO are used routinely in genetic counseling for identification of potential BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus are not practical for primary care. To address this gap, we develop and test a two-stage approach to genetic risk assessment by balancing the tradeoff between the amount of information used and accuracy achieved. The first stage is intended for primary care wherein limited information is collected and analyzed using a simplified version of BRCAPRO. If the assessed risk is sufficiently high, more extensive information is collected and the full BRCAPRO is used (stage two: intended for genetic counseling). We consider three first-stage tools: BRCAPROLYTE, BRCAPROLYTE-Plus, and BRCAPROLYTE-Simple. We evaluate the two-stage approach on independent clinical data on probands with family history of breast and ovarian cancers, and BRCA genetic test results. These include population-based data on 1344 probands from Newton-Wellesley Hospital and mostly high-risk family data on 2713 probands from Cancer Genetics Network and MD Anderson Cancer Center. We use discrimination and calibration measures, appropriately modified to evaluate the overall performance of a two-stage approach. We find that the proposed two-stage approach has very limited loss of discrimination and comparable calibration as BRCAPRO. It identifies a similar number of carriers without requiring a full family history evaluation on all probands. We conclude that the two-stage approach allows for practical large-scale genetic risk assessment in primary care.

AB - Genetic risk prediction models such as BRCAPRO are used routinely in genetic counseling for identification of potential BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus are not practical for primary care. To address this gap, we develop and test a two-stage approach to genetic risk assessment by balancing the tradeoff between the amount of information used and accuracy achieved. The first stage is intended for primary care wherein limited information is collected and analyzed using a simplified version of BRCAPRO. If the assessed risk is sufficiently high, more extensive information is collected and the full BRCAPRO is used (stage two: intended for genetic counseling). We consider three first-stage tools: BRCAPROLYTE, BRCAPROLYTE-Plus, and BRCAPROLYTE-Simple. We evaluate the two-stage approach on independent clinical data on probands with family history of breast and ovarian cancers, and BRCA genetic test results. These include population-based data on 1344 probands from Newton-Wellesley Hospital and mostly high-risk family data on 2713 probands from Cancer Genetics Network and MD Anderson Cancer Center. We use discrimination and calibration measures, appropriately modified to evaluate the overall performance of a two-stage approach. We find that the proposed two-stage approach has very limited loss of discrimination and comparable calibration as BRCAPRO. It identifies a similar number of carriers without requiring a full family history evaluation on all probands. We conclude that the two-stage approach allows for practical large-scale genetic risk assessment in primary care.

KW - BayesMendel

KW - BRCA1

KW - BRCA2

KW - BRCAPRO

KW - CancerGene

UR - http://www.scopus.com/inward/record.url?scp=84955640136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955640136&partnerID=8YFLogxK

U2 - 10.1007/s10549-016-3686-2

DO - 10.1007/s10549-016-3686-2

M3 - Article

VL - 155

SP - 375

EP - 383

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -